作者
Maaike C. Gerardsa, Ruben J. Terlou, Huixin Yu, C.H.W. Koks, V.E.A. Gerdes
发表日期
2015/4/12
期刊
Atherosclerosis
卷号
240
期号
2
页码范围
415-423
简介
Objective
To verify the safety and effectiveness of traditional Chinese red yeast rice-extract (RYR) for reduction of LDL cholesterol.
Methods
Systematic literature review and meta-analysis. Medline and EMBASE were searched until November 2014. We selected randomized studies in which RYR with a known content of the active substance monacolin K was tested against placebo or an active control group. Outcome measures were the effect of RYR on LDL cholesterol and incidence of adverse reactions with emphasis on liver and kidney injury and muscle symptoms.
Results
Twenty studies were analyzed. Quality of safety assessment was low in the majority of studies. RYR lowered LDL cholesterol with 1.02 mmol/L [−1.20; −0.83] compared to placebo. Effect of RYR on LDL was not different from statin therapy (0.03 mmol/L [−0.36; 0.41]). The incidence of liver and kidney injury was 0–5% and the risk was not different …
引用总数
2014201520162017201820192020202120222023202412141918172231242217